GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I

Biological diagnostics

GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.

Original languageEnglish (US)
Pages (from-to)66-81
Number of pages16
JournalAntiviral research
Volume166
DOIs
StatePublished - Jun 1 2019

Fingerprint

O'nyong-nyong Virus
Viruses
Epidemiologic Studies
Cryoglobulinemia
Acute Disease
Virus Diseases
Natural History
Disease Outbreaks
Communicable Diseases
Immunoglobulin M
Epidemiology
Public Health

Keywords

  • Alphavirus
  • Chikungunya virus
  • Diagnostics
  • Mayaro virus
  • O'nyong-nyong

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Cite this

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I : Biological diagnostics. / GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group.

In: Antiviral research, Vol. 166, 01.06.2019, p. 66-81.

Research output: Contribution to journalReview article

GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group. / GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I : Biological diagnostics. In: Antiviral research. 2019 ; Vol. 166. pp. 66-81.
@article{3b19905e8e5e4bd78a1a1ec0c251ce2c,
title = "GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics",
abstract = "The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.",
keywords = "Alphavirus, Chikungunya virus, Diagnostics, Mayaro virus, O'nyong-nyong",
author = "{GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group} and L. Pezzi and Reusken, {C. B.} and Scott Weaver and Drexler, {J. F.} and M. Busch and LaBeaud, {A. D.} and Diamond, {M. S.} and Nikos Vasilakis and Drebot, {M. A.} and Siqueira, {A. M.} and Ribeiro, {G. S.} and A. Kohl and M. Lecuit and Ng, {L. F.P.} and P. Gallian and {de Lamballerie}, X. and S. Boyer and P. Brasil and M. Diallo and Failloux, {A. B.} and T. Jaenisch and R. Louren{\cc}o-de-Oliveira and J. Neyts and M. Rios and Rodriguez-Morales, {A. J.} and Rosa-Freitas, {M. G.} and A. Sall and G. Simmons and F. Simon and {Vega Rua}, A.",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.antiviral.2019.03.009",
language = "English (US)",
volume = "166",
pages = "66--81",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I

T2 - Biological diagnostics

AU - GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group

AU - Pezzi, L.

AU - Reusken, C. B.

AU - Weaver, Scott

AU - Drexler, J. F.

AU - Busch, M.

AU - LaBeaud, A. D.

AU - Diamond, M. S.

AU - Vasilakis, Nikos

AU - Drebot, M. A.

AU - Siqueira, A. M.

AU - Ribeiro, G. S.

AU - Kohl, A.

AU - Lecuit, M.

AU - Ng, L. F.P.

AU - Gallian, P.

AU - de Lamballerie, X.

AU - Boyer, S.

AU - Brasil, P.

AU - Diallo, M.

AU - Failloux, A. B.

AU - Jaenisch, T.

AU - Lourenço-de-Oliveira, R.

AU - Neyts, J.

AU - Rios, M.

AU - Rodriguez-Morales, A. J.

AU - Rosa-Freitas, M. G.

AU - Sall, A.

AU - Simmons, G.

AU - Simon, F.

AU - Vega Rua, A.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.

AB - The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.

KW - Alphavirus

KW - Chikungunya virus

KW - Diagnostics

KW - Mayaro virus

KW - O'nyong-nyong

UR - http://www.scopus.com/inward/record.url?scp=85064536289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064536289&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2019.03.009

DO - 10.1016/j.antiviral.2019.03.009

M3 - Review article

VL - 166

SP - 66

EP - 81

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

ER -